StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Skinvisible's price to sales ratio was 42.2× on Oct 19, 2026, against 135.4× a year earlier. Over the last 5 years it ranged from 0.7× to 189.0×, with a median of 40.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202642.2×−20.1
2025Dec 31, 202562.3×−20.1
2024Dec 31, 202482.4×+63.4
2023Dec 29, 202319.0×+18.3
2022Dec 30, 20220.7×−1.3
2021Dec 31, 20212.0×−5.4
2020Dec 31, 20207.4×+1.5
2019Dec 31, 20195.9×−6.0
2018Dec 31, 201811.9×−24.7
2017Dec 29, 201736.6×+17.9
2016Dec 30, 201618.7×−1.0
2015Dec 31, 201519.7×−66.1
2014Dec 31, 201485.7×+76.0
2013Dec 31, 20139.7×−32.6
2012Dec 31, 201242.3×+2.4
2011Dec 30, 201139.9×–

More Skinvisible figures

See a number that looks wrong?